Explore
Validate
Learn
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- FAB391P - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human IGF-I R PE-conjugated Monoclonal Antibody (Clone 33255)
- Antibody type
- Monoclonal
- Antigen
- S. frugiperda insect ovarian cell line Sf 21-derived recombinant human IGF-I R, Glu31-Asn932
- Description
- Protein A or G purified from hybridoma culture supernatant
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Yellow dye
- Antigen sequence
P08069- Isotype
- IgG
- Vial size
- 100 Tests
Submitted references Quantification of IGF-1 Receptor May Be Useful in Diagnosing Polycythemia Vera-Suggestion to Be Added to Be One of the Minor Criterion.
Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.
Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells.
Clinical and functional characterization of a patient carrying a compound heterozygous pericentrin mutation and a heterozygous IGF1 receptor mutation.
Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I.
Wang JC, Shi G, Baptiste S, Yarotska M, Sindhu H, Wong C, Kalavar M, Gotlieb V, Bandarchuk A, Chen H
PloS one 2016;11(11):e0165299
PloS one 2016;11(11):e0165299
Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.
Mirkina I, Hadzijusufovic E, Krepler C, Mikula M, Mechtcheriakova D, Strommer S, Stella A, Jensen-Jarolim E, Höller C, Wacheck V, Pehamberger H, Valent P
PloS one 2014;9(1):e84417
PloS one 2014;9(1):e84417
Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells.
Mancini M, Gariboldi MB, Taiana E, Bonzi MC, Craparotta I, Pagin M, Monti E
British journal of cancer 2014 Jun 10;110(12):2865-73
British journal of cancer 2014 Jun 10;110(12):2865-73
Clinical and functional characterization of a patient carrying a compound heterozygous pericentrin mutation and a heterozygous IGF1 receptor mutation.
Müller E, Dunstheimer D, Klammt J, Friebe D, Kiess W, Kratzsch J, Kruis T, Laue S, Pfäffle R, Wallborn T, Heidemann PH
PloS one 2012;7(5):e38220
PloS one 2012;7(5):e38220
Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I.
Raile K, Hille R, Laue S, Schulz A, Pfeifer G, Horn F, Kiess W
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2003 Nov-Dec;35(11-12):786-93
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2003 Nov-Dec;35(11-12):786-93
No comments: Submit comment
No validations: Submit validation data